REQUEST A DEMO
Total
USD $0.00
Search more companies

Visen Pharmaceuticals (维升药业) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Visen Pharmaceuticals Profile Updated: May 27, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Visen Pharmaceuticals (维升药业) is an enterprise located in China, with the main office in Suzhou. The company operates in the Pharmaceutical and Medicine Manufacturing sector. Visen Pharmaceuticals (维升药业) was incorporated on April 03, 2026. During that time, Visen Pharmaceuticals (维升药业)’s total assets grew by 232.61%.

Headquarters
Room 3-108, 3rd Floor, Building B, Hengtai Ideal Innovation Building, No. 69 Jiuzhang Road, Suzhou, China
Suzhou; Jiangsu;

Contact Details: Purchase the Visen Pharmaceuticals (维升药业) report to view the information.

Website: http://www.visenpharma.com

Basic Information
Outstanding Shares:
Purchase the Visen Pharmaceuticals (维升药业) report to view the information.
Financial Auditors:
Purchase the Visen Pharmaceuticals (维升药业) report to view the information.
Incorporation Date:
April 03, 2026
Ownership Details
Purchase this report to view the information.
32.14%
Purchase this report to view the information.
18.29%
Purchase this report to view the information.
11.43%
Purchase this report to view the information.
6.86%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Visen Pharmaceuticals (维升药业) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total Operating Revenue
-89.37%
Operating Profit
-30.76%
EBITDA
-33.42%
Net Profit/Loss for the Period
-39.06%
Total Assets
232.61%
Total Equity
215.84%
Return on Equity (ROE)
42.27%
Debt / Equity
22248%
Quick Ratio
193.55%
Cash Ratio
-0.9%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?